Welcome to our dedicated page for Dupont De Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DuPont de Nemours, Inc. filings document the regulatory disclosures of a Delaware specialty materials company with common stock listed on the New York Stock Exchange under DD. Its 8-K reports cover operating and financial results, Regulation FD disclosures, material events, board composition changes, corporate-governance matters and capital-structure disclosures.
DuPont proxy materials describe annual stockholder voting matters, director elections, governance practices, executive compensation and proposals affecting the company’s certificate of incorporation and common stock. Recent filings also document separation-related matters, including disclosures connected with the completed Qnity Electronics spin-off, as well as agreements and percentage calculations tied to the post-separation corporate structure.
DuPont de Nemours, Inc. uses this 10-K to describe its transformation into a focused advanced solutions company serving healthcare, water, construction and industrial markets. The company operates globally in about 50 countries with manufacturing in about 20 countries.
DuPont completed the spin-off of its semiconductor and interconnect solutions businesses as Qnity Electronics in November 2025, treating Qnity, prior M&M divestitures and the planned Aramids sale as discontinued operations. Segment reporting was realigned into Healthcare & Water Technologies and Diversified Industrials, each built around branded materials and engineered solutions.
The filing highlights acquisitions such as Spectrum Plastics, Donatelle and Sinochem to deepen medical and water technologies, a $2 billion share repurchase authorization with a $500 million ASR, and extensive risk disclosures around complex tax and indemnity arrangements, PFAS cost-sharing, supply chains, regulation, cybersecurity and global economic and trade exposure.
DuPont de Nemours reported flat fourth-quarter 2025 net sales of $1.7 billion, with organic sales down 1% after a timing shift from system cut-over activities. The quarter showed a GAAP loss from continuing operations of $108 million, but operating EBITDA rose 4% to $409 million and adjusted EPS increased to $0.46 from $0.39. Transaction-adjusted free cash flow reached $228 million.
For full year 2025, net sales grew 2% to $6.8 billion, led by 7% organic growth in Healthcare & Water Technologies, partly offset by declines in Diversified Industrials. GAAP income from continuing operations was $98 million versus a prior-year loss, while operating EBITDA rose to $1.63 billion and adjusted EPS climbed 16% to $1.68. Transaction-adjusted free cash flow was $689 million.
The company completed the separation of its Electronics business into Qnity Electronics and is progressing on the planned Aramids divestiture, expected to close around the end of first-quarter 2026. For 2026, DuPont guides to net sales of $7.075–$7.135 billion, operating EBITDA of $1.725–$1.755 billion, and adjusted EPS of $2.25–$2.30, implying continued margin strength and earnings growth.
DuPont de Nemours, Inc. director Donald G. Macpherson filed an initial Form 3 reporting his beneficial ownership. As of the event date of January 20, 2026, he reports beneficial ownership of 0 shares of DuPont common stock, held directly.
DuPont de Nemours, Inc. reported that its Board of Directors has appointed D.G. Macpherson to the Board, effective immediately as of January 20, 2026. The Board determined that he qualifies as an independent director under New York Stock Exchange standards, SEC rules, and the company’s Corporate Governance Guidelines.
Macpherson, age 58, is the Chief Executive Officer and Chairman of W.W. Grainger, Inc., having served as CEO since 2016 and Chairman since 2017, following earlier senior operating roles at Grainger. His background also includes leadership at Boston Consulting Group and engineering experience in the U.S. Air Force, supported by degrees from Stanford University and Northwestern’s Kellogg School of Management.
DuPont stated there is no special arrangement or understanding under which he was selected and no related-party transactions requiring disclosure. He will receive DuPont’s standard compensation for non-employee directors. A press release announcing his appointment is included as Exhibit 99.1.
A DuPont de Nemours, Inc. director reported an automatic share withholding to cover taxes on vested equity awards. On 12/31/2025, 24,574 shares of DuPont common stock were withheld at a price of $40.402 per share, coded as a tax-related transaction. After this withholding, the director beneficially owns about 301,048.2755 shares, held directly. The explanation notes that the withheld shares relate to lapsed restricted stock units and associated dividend equivalent units, indicating this was a routine tax settlement rather than an open-market trade.
DuPont de Nemours, Inc. executive Senior Vice President & CHRO reported a routine share withholding related to equity compensation. On 12/31/2025, the reporting person had 2,793 shares of common stock withheld, identified as taxes on lapsed restricted stock units and associated dividend equivalent units, at a price of $40.402 per share. After this tax-related transaction, the executive beneficially owned 80,255.4371 shares of DuPont common stock directly, which the filing notes includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. reported an insider stock transaction by its CEO, who also serves as a director. On 12/31/2025, the insider had 6,704 shares of common stock disposed of in a transaction coded "F" at a price of $40.402 per share. This code indicates shares were withheld to cover taxes on the vesting of previously granted restricted stock units and related dividend equivalents, rather than an open-market sale. After this tax withholding, the insider beneficially owned 282,592.5773 shares of DuPont common stock, held directly.
DuPont de Nemours, Inc. reported an insider equity transaction involving its SVP & General Counsel. On 12/31/2025, 3,353 shares of common stock were disposed of in a transaction coded "F" at $40.402 per share, which the explanation states reflected taxes withheld on lapsed restricted stock units (RSUs) and associated dividend equivalent units. Following this tax‑related withholding, the insider directly beneficially owned 109,030.2689 shares of DuPont common stock, which includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. insider updates share holdings. A senior vice president and chief financial officer reported the disposition of 536 shares of common stock on 12/31/2025 at a price of $40.402 per share. The filing explains that the shares were withheld to pay taxes on lapsed restricted stock units and related dividend equivalent units. After this tax-related transaction, the insider beneficially owns 52,302.0877 shares of DuPont common stock in direct ownership, which reflects ongoing dividend reinvestment activity.
DuPont de Nemours, Inc. insider plans stock sale under Rule 144. A holder intends to sell 1,922 shares of DuPont de Nemours common stock through Merrill Lynch on the NYSE, with an aggregate market value of $79,724.56. These shares were acquired on 12/31/2025 through the vesting of a restricted stock unit award granted under the company’s equity compensation plan.
As context, DuPont de Nemours had 418,975,324 common shares outstanding. Over the prior three months, the same seller disposed of 72,958 common shares for gross proceeds of $2,993,940.97. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the company’s current or prospective operations.